hydralazine hydrochloride and isosorbide dinitrate

FDA Drug Profile — isosorbide dinitrate and hydralazine hydrochloride

Drug Details

Generic Name
hydralazine hydrochloride and isosorbide dinitrate
Brand Names
isosorbide dinitrate and hydralazine hydrochloride
Application Number
NDA020727
Sponsor
Bryant Ranch Prepack
NDC Codes
2
Dosage Forms
TABLET, FILM COATED
Routes
ORAL
Active Ingredients
HYDRALAZINE HYDROCHLORIDE, ISOSORBIDE DINITRATE

Indications and Usage

1 INDICATIONS AND USAGE Isosorbide dinitrate and hydralazine hydrochloride tablets are a combination of isosorbide dinitrate, a nitrate vasodilator, and hydralazine hydrochloride, an arteriolar vasodilator, indicated for: the treatment of heart failure as an adjunct therapy to standard therapy in self-identified black patients to improve survival, prolong time to hospitalization for heart failure and to improve patient-reported functional status ( 1.1 ) Limitations of use: There is little experience in patients with NYHA class IV heart failure ( 1.2 ) 1.1 Treatment of Heart Failure in Self-identified Black Patients Isosorbide dinitrate and hydralazine hydrochloride tablets are indicated for the treatment of heart failure as an adjunct to standard therapy in self-identified black patients to improve survival, to prolong time to hospitalization for heart failure, and to improve patient-reported functional status. 1.2 Limitations of Use There is little experience in patients with NYHA class IV heart failure.